December 28, 2012 — The past year in cardiology has continued to see progress and innovation in medicine. As the year ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
December 28, 2012 — Researchers have discovered that adding lovastatin, a widely used cholesterol-lowering drug, to ...
December 28, 2012
December 20, 2012 — The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and the public ...
December 20, 2012
December 10, 2012 — The U.S. Food and Drug Administration (FDA) is notifying healthcare professionals, caregivers and ...
December 10, 2012
One-year results from the ADAPT-DES Trial were presented during TCT 2012. It examined patient hyporesponsiveness to ...
December 07, 2012December 6, 2012 — Daiichi Sankyo Inc. and Eli Lilly and Co. announced results of two retrospective, observational ...
December 06, 2012
November 30, 2012 — Results of a study investigating the effects of smoking on the antiplatelet medications clopidogrel ...
November 30, 2012November 30, 2012 — A large observational study found the increased risk associated with dual antiplatelet therapy cessa ...
November 30, 2012Use of Rosuvastatin Prior to Angioplasty Does Not Influence Troponin I Release Following Angioplasty
November 9, 2012 — A study found that the use of rosuvastatin prior to angioplasty did not influence the levels of ...
November 09, 2012November 9, 2012 — Bristol-Myers Squibb Co. and Pfizer Inc. announced that the reductions in stroke or systemic embolism ...
November 09, 2012
November 7, 2012 — Janssen Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has approved ...
November 07, 2012
November 2, 2012 — Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are ...
November 02, 2012October 23, 2012 — A study found that a tailored therapy approach that adjusts the loading dose of clopidogrel according ...
October 23, 2012October 16, 2012 — Proteon Therapeutics Inc. has initiated enrollment in a Phase 1 clinical study of its lead product ...
October 16, 2012
October 4, 2012 — This year’s European Society of Cardiology (ESC) Congress in Munich, Germany, was a stark example of ...
October 04, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now